Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival

Kidney International

Volumn 77, Issue 6, 2010, Pages 527-535

  Murugan, Raghavan ^a   Karajala Subramanyam, Vijay ^a   Lee, Minjae ^a,b   Yende, Sachin ^a   Kong, Lan ^a,b   Carter, Melinda ^a   Angus, Derek C ^a   Kellum, John A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Acute kidney injury; Inflammation; Mortality; Pneumonia; Severe sepsis; Severity

Indexed keywords

ANTIBIOTIC AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 9; D DIMER; INTERLEUKIN 10; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR;

AGED; ARTICLE; BLOOD SAMPLING; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GENDER; HEART DISEASE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; KIDNEY INJURY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS; SURVIVAL;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; CRITICAL ILLNESS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HOSPITALIZATION; HUMANS; IMMUNE SYSTEM PROCESSES; INTENSIVE CARE UNITS; INTERLEUKIN-6; KIDNEY; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES;

EID: 77949502307     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.502     Document Type: Article

References (42)

1. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-818.
2. Bagshaw SM, Uchino S, Bellomo R et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007; 2: 431-439.
3. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004; 351: 159-169.
4. Chen YC, Jenq CC, Tian YC et al. RIFLE classification for predicting in-hospital mortality in critically ill sepsis patients. Shock 2009; 31: 139-145.
5. Bagshaw SM, George C, Bellomo R. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 2008; 12: R47.
6. Yegenaga I, Hoste E, Van Biesen W et al. Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: results of a prospective study. Am J Kidney Dis 2004; 43: 817-824.
7. Janssen vD, Spapen H, Geers C et al. Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment? Acta Anaesthesiol Scand 2008; 52: 1259-1264.
8. Lopes JA, Jorge S, Resina C et al. Acute kidney injury in patients with sepsis: a contemporary analysis. Int J Infect Dis 2009; 13: 176-181.
9. Angus DC, Linde-Zwirble WT, Lidicker J et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310.
10. Vincent JL, Moreno R, Takala J et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-710.
11. Abraham E, Reinhart K, Opal S et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003; 290: 238-247.
12. Bernard GR, Vincent JL, Laterre PF et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
13. Warren BL, Eid A, Singer P et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001; 286: 1869-1878.
14. Fiedler VB, Loof I, Sander E et al. Monoclonal antibody to tumor necrosis factor-alpha prevents lethal endotoxin sepsis in adult rhesus monkeys. J Lab Clin Med 1992; 120: 574-588.
15. Knotek M, Rogachev B, Wang W et al. Endotoxemic renal failure in mice: role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 2001; 59: 2243-2249.
16. Cunningham PN, Dyanov HM, Park P et al. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002; 168: 5817-5823.
17. Chawla LS, Seneff MG, Nelson DR et al. Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis. Clin J Am Soc Nephrol 2007; 2: 22-30.
18. Iglesias J, Marik PE, Levine JS. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock. Am J Kidney Dis 2003; 41: 62-75.
19. Garcia-Fernandez N, Montes R, Purroy A et al. Hemostatic disturbances in patients with systemic inflammatory response syndrome (SIRS) and associated acute renal failure (ARF). Thromb Res 2000; 100: 19-25.
20. Nathan C. Points of control in inflammation. Nature 2002; 420: 846-852.
21. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195.
22. Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
23. Lim WS, van der Eerden MM, Laing R et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-382.
24. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256.
25. Halm EA, Teirstein AS. Clinical practice. Management of community-acquired pneumonia. N Engl J Med 2002; 347: 2039-2045.
26. Bihorac A, Yavas S, Subbiah S et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg 2009; 249: 851-858.
27. Coca SG, Peixoto AJ, Garg AX et al. The prognostic importance of a small acute decrement in kidney function in hospitalized patients: a systematic review and meta-analysis. Am J Kidney Dis 2007; 50: 712-720.
28. Newsome BB, Warnock DG, McClellan WM et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 2008; 168: 609-616.
29. Simmons EM, Himmelfarb J, Sezer MT et al. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 2004; 65: 1357-1365.
30. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure\definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212.
31. Bagshaw SM, Uchino S, Cruz D et al. A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury. Nephrol Dial Transplant 2009; 24: 2739-2744.
32. Kellum JA, Kong L, Fink MP et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) study. Arch Intern Med 2007; 167: 1655-1663.
33. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
34. Knaus WA, Wagner DP, Draper EA et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619-1636.
35. Aujesky D, Auble TE, Yealy DM et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 2005; 118: 384-392.
36. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266.
37. Hoste EA, Clermont G, Kersten A et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006; 10: R73.
38. Yealy DM, Auble TE, Stone RA et al. Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med 2005; 143: 881-894.
39. Kasal J, Jovanovic Z, Clermont G et al. Comparison of Cox and Gray's survival models in severe sepsis. Crit Care Med 2004; 32: 700-707.
40. Tobin J. Estimation of relationships for limited dependent variables. Econometrica 1958; 26: 24-36.
41. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 38: 963-974.
42. Epstein MP, Lin X, Boehnke M. A tobit variance-component method for linkage analysis of censored trait data. Am J Hum Genet 2003; 72: 611-620.